The Center for Dermatology Research is supported by an unrestricted educational grant from Galderma Laboratories, L.P. Dr. Feldman is a consultant and speaker for Galderma, Connetics, Abbott Labs, Warner Chilcott, Centocor, Amgen, Photomedex, Genentech, BiogenIdec, Taro, and Bristol Myers Squibb. Dr. Feldman has received grants from Galderma, Connetics, Astellas, Abbott Labs, Warner Chilcott, Centocor, Amgen, Photomedex, Genentech, BiogenIdec, Coria, Pharmaderm, Ortho Pharmaceuticals, Aventis Pharmaceuticals, Roche Dermatology, 3M, Bristol Myers Squibb, Stiefel, GlaxoSmithKline, and Novartis and stock options from Photomedex. Drs. Pearce, Sandoval, and Williford have no conflicts to disclose.
Commentary: The Growing Skin Cancer Problem
Article first published online: 2 APR 2013
© 2012 by the American Society for Dermatologic Surgery, Inc. Published by Wiley Periodicals, Inc.
Volume 39, Issue 4, pages 603–604, April 2013
How to Cite
Pearce, D., Sandoval, L. F., Feldman, S. R. and Williford, P. M. (2013), Commentary: The Growing Skin Cancer Problem. Dermatologic Surgery, 39: 603–604. doi: 10.1111/dsu.12076
- Issue published online: 2 APR 2013
- Article first published online: 2 APR 2013